Trial NCT02110069

View at ClinicalTrials.gov 
Org. Study IDs: SIR-DA-1202
Secondary IDs: 1R01FD004363-01A1 2013-2339

Last trial update was posted on 2023-09-21

MeSH Interventions

Sirolimus Vincristine

MeSH Conditions

Hemangioendothelioma Hemangioma Kasabach-Merritt Syndrome Sarcoma, Kaposi

Other Conditions

Kaposiform Hemangioendothelioma (KHE) Tufted Angioma

Stopping Reasons

This study was challenged by the incidence of KHE with KMP as this continued to be extremely rare, and very sporadic. In July of 2019 grant renewal funding ended.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID